Kirsten Cecilie Odegard, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 22 | 2023 | 4671 | 1.820 |
Why?
|
| Anesthesia, General | 6 | 2016 | 1173 | 1.020 |
Why?
|
| Anesthesia | 7 | 2020 | 1591 | 0.940 |
Why?
|
| Conscious Sedation | 3 | 2016 | 531 | 0.880 |
Why?
|
| Fontan Procedure | 7 | 2015 | 796 | 0.770 |
Why?
|
| Blood Coagulation Factors | 4 | 2007 | 366 | 0.630 |
Why?
|
| Pulmonary Atresia | 1 | 2017 | 159 | 0.530 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2022 | 477 | 0.480 |
Why?
|
| Heart Arrest | 4 | 2016 | 1513 | 0.480 |
Why?
|
| Anesthesiology | 3 | 2020 | 1120 | 0.430 |
Why?
|
| Anesthetics, Inhalation | 4 | 2021 | 572 | 0.410 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2023 | 594 | 0.370 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2022 | 451 | 0.360 |
Why?
|
| Consensus | 2 | 2016 | 3117 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7389 | 0.330 |
Why?
|
| Heart Ventricles | 4 | 2023 | 3796 | 0.330 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 1161 | 0.300 |
Why?
|
| Anesthetics, Intravenous | 3 | 2005 | 394 | 0.290 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2007 | 188 | 0.260 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 350 | 0.250 |
Why?
|
| Child, Preschool | 26 | 2022 | 42188 | 0.250 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 380 | 0.250 |
Why?
|
| Thrombosis | 3 | 2016 | 2943 | 0.250 |
Why?
|
| Infant | 26 | 2021 | 36152 | 0.240 |
Why?
|
| Anesthesia, Intravenous | 1 | 2005 | 129 | 0.240 |
Why?
|
| Venae Cavae | 1 | 2004 | 40 | 0.230 |
Why?
|
| Societies, Medical | 1 | 2016 | 3900 | 0.230 |
Why?
|
| Infant, Newborn | 17 | 2023 | 26180 | 0.230 |
Why?
|
| Hemodynamics | 5 | 2013 | 4160 | 0.230 |
Why?
|
| Child | 26 | 2022 | 80079 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 1 | 2015 | 1924 | 0.220 |
Why?
|
| Etomidate | 1 | 2005 | 185 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2021 | 3621 | 0.190 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2021 | 42 | 0.190 |
Why?
|
| Blood Coagulation | 1 | 2007 | 1154 | 0.180 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2021 | 1092 | 0.180 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2020 | 48 | 0.180 |
Why?
|
| Flagellin | 1 | 2021 | 124 | 0.180 |
Why?
|
| Postoperative Complications | 3 | 2018 | 15612 | 0.160 |
Why?
|
| Thrombophilia | 1 | 2002 | 306 | 0.160 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 64 | 0.160 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 143 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2000 | 216 | 0.160 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2020 | 345 | 0.150 |
Why?
|
| Incidence | 9 | 2019 | 21337 | 0.150 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2000 | 285 | 0.150 |
Why?
|
| Ventricular Septum | 1 | 2017 | 75 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2021 | 621 | 0.140 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2016 | 128 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2018 | 367 | 0.120 |
Why?
|
| Rewarming | 1 | 2015 | 64 | 0.120 |
Why?
|
| Isoflurane | 3 | 2021 | 384 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 716 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2019 | 1526 | 0.110 |
Why?
|
| Hypothermia | 1 | 2015 | 188 | 0.110 |
Why?
|
| Humans | 42 | 2023 | 760617 | 0.100 |
Why?
|
| Female | 30 | 2021 | 392148 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2020 | 2764 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2018 | 7960 | 0.100 |
Why?
|
| Adolescent | 12 | 2022 | 88234 | 0.100 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2012 | 129 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1285 | 0.100 |
Why?
|
| Body Temperature | 1 | 2015 | 780 | 0.100 |
Why?
|
| Retrospective Studies | 13 | 2023 | 80566 | 0.100 |
Why?
|
| Male | 28 | 2021 | 360358 | 0.100 |
Why?
|
| Neuromuscular Blockade | 1 | 2012 | 147 | 0.090 |
Why?
|
| Prospective Studies | 12 | 2016 | 54360 | 0.090 |
Why?
|
| Angiography | 1 | 2016 | 1596 | 0.090 |
Why?
|
| Heart | 1 | 2004 | 4403 | 0.090 |
Why?
|
| Midazolam | 2 | 2004 | 266 | 0.090 |
Why?
|
| Patient Admission | 1 | 2017 | 1365 | 0.090 |
Why?
|
| ROC Curve | 1 | 2017 | 3575 | 0.080 |
Why?
|
| Fentanyl | 2 | 2004 | 433 | 0.080 |
Why?
|
| Hemostasis, Surgical | 1 | 2009 | 126 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3672 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1467 | 0.080 |
Why?
|
| Parents | 1 | 2002 | 3563 | 0.070 |
Why?
|
| Blood Coagulation Tests | 1 | 2009 | 271 | 0.070 |
Why?
|
| Risk Factors | 8 | 2022 | 74115 | 0.070 |
Why?
|
| Head-Down Tilt | 1 | 2007 | 65 | 0.070 |
Why?
|
| Boston | 1 | 2020 | 9313 | 0.070 |
Why?
|
| Valsalva Maneuver | 1 | 2007 | 98 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 36402 | 0.070 |
Why?
|
| Anxiety | 1 | 2002 | 4570 | 0.070 |
Why?
|
| Factor VIII | 1 | 2009 | 348 | 0.070 |
Why?
|
| Survival Rate | 2 | 2017 | 12719 | 0.070 |
Why?
|
| Jugular Veins | 1 | 2007 | 210 | 0.070 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2006 | 91 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2023 | 64568 | 0.060 |
Why?
|
| Palliative Care | 2 | 2023 | 3592 | 0.060 |
Why?
|
| Pulmonary Artery | 2 | 2023 | 1927 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2016 | 1462 | 0.060 |
Why?
|
| Pancuronium | 1 | 2004 | 44 | 0.060 |
Why?
|
| Heart Septal Defects | 1 | 2005 | 190 | 0.060 |
Why?
|
| Constriction | 1 | 2004 | 168 | 0.060 |
Why?
|
| Macrophages | 1 | 2019 | 5758 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 251 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 656 | 0.060 |
Why?
|
| Factor X | 1 | 2003 | 64 | 0.050 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2004 | 143 | 0.050 |
Why?
|
| Medical Illustration | 1 | 2004 | 135 | 0.050 |
Why?
|
| Plasminogen | 1 | 2003 | 144 | 0.050 |
Why?
|
| Antithrombin III | 1 | 2003 | 128 | 0.050 |
Why?
|
| Protein C | 1 | 2003 | 133 | 0.050 |
Why?
|
| Factor VII | 1 | 2003 | 139 | 0.050 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2005 | 266 | 0.050 |
Why?
|
| Prothrombin | 1 | 2003 | 190 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2005 | 737 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2009 | 1299 | 0.050 |
Why?
|
| Factor V | 1 | 2003 | 167 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 9998 | 0.050 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 526 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2004 | 406 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2005 | 930 | 0.050 |
Why?
|
| Gadolinium | 1 | 2007 | 959 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 2630 | 0.050 |
Why?
|
| Inflammation | 1 | 2021 | 10760 | 0.050 |
Why?
|
| Comorbidity | 1 | 2015 | 10505 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2013 | 2241 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2023 | 5239 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2012 | 3232 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2021 | 696 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2018 | 41457 | 0.040 |
Why?
|
| Neutrophils | 2 | 2021 | 3763 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2004 | 1048 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 1229 | 0.040 |
Why?
|
| Hemangioma | 1 | 2002 | 727 | 0.040 |
Why?
|
| Attitude | 1 | 2002 | 772 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2006 | 3680 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 1779 | 0.030 |
Why?
|
| Sheep | 1 | 2019 | 1436 | 0.030 |
Why?
|
| Age Factors | 3 | 2019 | 18381 | 0.030 |
Why?
|
| Oxygen | 2 | 2005 | 4226 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 1331 | 0.030 |
Why?
|
| Spinal Neoplasms | 1 | 2002 | 703 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1096 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2015 | 23972 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2002 | 789 | 0.030 |
Why?
|
| Electromyography | 1 | 2000 | 1393 | 0.030 |
Why?
|
| Adult | 6 | 2022 | 220969 | 0.030 |
Why?
|
| Polyethylene Terephthalates | 1 | 2015 | 112 | 0.030 |
Why?
|
| Reference Values | 1 | 2002 | 4919 | 0.030 |
Why?
|
| Antiemetics | 1 | 2016 | 186 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 16967 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 4433 | 0.030 |
Why?
|
| Contrast Media | 1 | 2007 | 5305 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
| Body Weight | 1 | 2004 | 4614 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2015 | 292 | 0.030 |
Why?
|
| Propofol | 1 | 2019 | 602 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 1272 | 0.030 |
Why?
|
| Data Collection | 1 | 2002 | 3315 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15498 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2021 | 2481 | 0.030 |
Why?
|
| Catheter Ablation | 1 | 2005 | 2634 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1884 | 0.030 |
Why?
|
| Fibrinogen | 2 | 2009 | 887 | 0.020 |
Why?
|
| Parasympathetic Nervous System | 1 | 2012 | 143 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2016 | 599 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2016 | 5293 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2315 | 0.020 |
Why?
|
| Liver | 1 | 2007 | 7512 | 0.020 |
Why?
|
| Logistic Models | 2 | 2007 | 13245 | 0.020 |
Why?
|
| Registries | 1 | 2007 | 8207 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4269 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2012 | 242 | 0.020 |
Why?
|
| Pediatrics | 2 | 2016 | 3588 | 0.020 |
Why?
|
| Collagen Type VIII | 1 | 2009 | 15 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 58894 | 0.020 |
Why?
|
| Echocardiography | 1 | 2022 | 4987 | 0.020 |
Why?
|
| Heparin Antagonists | 1 | 2009 | 34 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 519 | 0.020 |
Why?
|
| United States | 1 | 2017 | 72272 | 0.020 |
Why?
|
| Protamines | 1 | 2009 | 112 | 0.020 |
Why?
|
| Head | 1 | 2015 | 922 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2009 | 169 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12043 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9345 | 0.020 |
Why?
|
| Blood Volume | 1 | 2009 | 547 | 0.020 |
Why?
|
| Hematocrit | 1 | 2009 | 623 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 436 | 0.020 |
Why?
|
| Heart Bypass, Right | 1 | 2007 | 75 | 0.020 |
Why?
|
| Platelet Count | 1 | 2009 | 780 | 0.020 |
Why?
|
| Aged | 3 | 2015 | 169042 | 0.020 |
Why?
|
| Mice | 3 | 2021 | 81368 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2009 | 636 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 220584 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15576 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 574 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 982 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15828 | 0.010 |
Why?
|
| Vasodilation | 1 | 2007 | 962 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8833 | 0.010 |
Why?
|
| Time Factors | 2 | 2016 | 39913 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15251 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8618 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 1182 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3879 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39063 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 293 | 0.010 |
Why?
|
| Animals | 3 | 2021 | 168201 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 2002 | 255 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2001 | 510 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4570 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1376 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 1407 | 0.010 |
Why?
|
| Hormones | 1 | 2001 | 869 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 6961 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2214 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2001 | 1813 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10199 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 3998 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29600 | 0.010 |
Why?
|
| Inpatients | 1 | 2007 | 2544 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3492 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5073 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 9643 | 0.010 |
Why?
|
| Length of Stay | 1 | 2007 | 6418 | 0.010 |
Why?
|
| Health Status | 1 | 2007 | 4075 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7583 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 12758 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 6174 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18937 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 8542 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 14018 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10754 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12334 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 59179 | 0.000 |
Why?
|